Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer
Resistance to Herceptin represents a major challenge for successful treatment of HER2-positive breast cancer. Here, the authors demonstrate that the activation of the IGF2/IRS1 signal caused by disruption of a negative feedback loop between FOXO3a-miR-128/miR-30/miR-193 induces Herceptin resistance.
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2ab2374f4c049a490b02ad183f4c03c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c2ab2374f4c049a490b02ad183f4c03c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c2ab2374f4c049a490b02ad183f4c03c2021-12-02T15:36:11ZDisruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer10.1038/s41467-021-23052-92041-1723https://doaj.org/article/c2ab2374f4c049a490b02ad183f4c03c2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23052-9https://doaj.org/toc/2041-1723Resistance to Herceptin represents a major challenge for successful treatment of HER2-positive breast cancer. Here, the authors demonstrate that the activation of the IGF2/IRS1 signal caused by disruption of a negative feedback loop between FOXO3a-miR-128/miR-30/miR-193 induces Herceptin resistance.Liyun LuoZhijie ZhangNi QiuLi LingXiaoting JiaYing SongHongsheng LiJiansheng LiHui LyuHao LiuZhimin HeBolin LiuGuopei ZhengNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-16 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Liyun Luo Zhijie Zhang Ni Qiu Li Ling Xiaoting Jia Ying Song Hongsheng Li Jiansheng Li Hui Lyu Hao Liu Zhimin He Bolin Liu Guopei Zheng Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer |
description |
Resistance to Herceptin represents a major challenge for successful treatment of HER2-positive breast cancer. Here, the authors demonstrate that the activation of the IGF2/IRS1 signal caused by disruption of a negative feedback loop between FOXO3a-miR-128/miR-30/miR-193 induces Herceptin resistance. |
format |
article |
author |
Liyun Luo Zhijie Zhang Ni Qiu Li Ling Xiaoting Jia Ying Song Hongsheng Li Jiansheng Li Hui Lyu Hao Liu Zhimin He Bolin Liu Guopei Zheng |
author_facet |
Liyun Luo Zhijie Zhang Ni Qiu Li Ling Xiaoting Jia Ying Song Hongsheng Li Jiansheng Li Hui Lyu Hao Liu Zhimin He Bolin Liu Guopei Zheng |
author_sort |
Liyun Luo |
title |
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer |
title_short |
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer |
title_full |
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer |
title_fullStr |
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer |
title_full_unstemmed |
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer |
title_sort |
disruption of foxo3a-mirna feedback inhibition of igf2/igf-1r/irs1 signaling confers herceptin resistance in her2-positive breast cancer |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/c2ab2374f4c049a490b02ad183f4c03c |
work_keys_str_mv |
AT liyunluo disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT zhijiezhang disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT niqiu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT liling disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT xiaotingjia disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT yingsong disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT hongshengli disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT jianshengli disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT huilyu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT haoliu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT zhiminhe disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT bolinliu disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer AT guopeizheng disruptionoffoxo3amirnafeedbackinhibitionofigf2igf1rirs1signalingconfersherceptinresistanceinher2positivebreastcancer |
_version_ |
1718386379387305984 |